These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Measuring Parkinson's disease over time: The real-world within-subject reliability of the MDS-UPDRS. Evers LJW; Krijthe JH; Meinders MJ; Bloem BR; Heskes TM Mov Disord; 2019 Oct; 34(10):1480-1487. PubMed ID: 31291488 [TBL] [Abstract][Full Text] [Related]
9. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Berg D; Postuma RB; Bloem B; Chan P; Dubois B; Gasser T; Goetz CG; Halliday GM; Hardy J; Lang AE; Litvan I; Marek K; Obeso J; Oertel W; Olanow CW; Poewe W; Stern M; Deuschl G Mov Disord; 2014 Apr; 29(4):454-62. PubMed ID: 24619848 [TBL] [Abstract][Full Text] [Related]
10. The Emergence and Progression of Motor Dysfunction in Individuals at Risk of Parkinson's Disease. Simonet C; Mahlknecht P; Marini K; Seppi K; Gill A; Bestwick JP; Lees AJ; Giovannoni G; Schrag A; Noyce AJ Mov Disord; 2023 Sep; 38(9):1636-1644. PubMed ID: 37317903 [TBL] [Abstract][Full Text] [Related]
11. Defining the Riddle in Order to Solve It: There Is More Than One "Parkinson's Disease". Outeiro TF; Alcalay RN; Antonini A; Attems J; Bonifati V; Cardoso F; Chesselet MF; Hardy J; Madeo G; McKeith I; Mollenhauer B; Moore DJ; Rascol O; Schlossmacher MG; Soreq H; Stefanis L; Ferreira JJ Mov Disord; 2023 Jul; 38(7):1127-1142. PubMed ID: 37156737 [TBL] [Abstract][Full Text] [Related]
12. Parkinson's Disease in the Middle East, North Africa, and South Asia: Consensus from the International Parkinson and Movement Disorder Society Task Force for the Middle East. Khalil H; Chahine LM; Siddiqui J; Salari M; El-Jaafary S; Aldaajani Z; Abu Al-Melh M; Mohammad TM; Abu Snineh M; Syed NA; Bhatt M; Habib MA; Habahbeh M; Tabbal SD; Jeon B; Bajwa JA J Parkinsons Dis; 2020; 10(2):729-741. PubMed ID: 32176653 [TBL] [Abstract][Full Text] [Related]
13. Identification of Parkinson's Disease Subtypes from Resting-State Electroencephalography. Yassine S; Gschwandtner U; Auffret M; Duprez J; Verin M; Fuhr P; Hassan M Mov Disord; 2023 Aug; 38(8):1451-1460. PubMed ID: 37310340 [TBL] [Abstract][Full Text] [Related]
14. Subtypes of Parkinson's Disease: What Do They Tell Us About Disease Progression? Fereshtehnejad SM; Postuma RB Curr Neurol Neurosci Rep; 2017 Apr; 17(4):34. PubMed ID: 28324303 [TBL] [Abstract][Full Text] [Related]
15. European Academy of Neurology/Movement Disorder Society-European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies. Deuschl G; Antonini A; Costa J; Śmiłowska K; Berg D; Corvol JC; Fabbrini G; Ferreira J; Foltynie T; Mir P; Schrag A; Seppi K; Taba P; Ruzicka E; Selikhova M; Henschke N; Villanueva G; Moro E Mov Disord; 2022 Jul; 37(7):1360-1374. PubMed ID: 35791767 [TBL] [Abstract][Full Text] [Related]
17. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort. Regnault A; Boroojerdi B; Meunier J; Bani M; Morel T; Cano S J Neurol; 2019 Aug; 266(8):1927-1936. PubMed ID: 31073716 [TBL] [Abstract][Full Text] [Related]
18. Subtypes of Parkinson's disease: state of the field and future directions. Marras C Curr Opin Neurol; 2015 Aug; 28(4):382-6. PubMed ID: 26110797 [TBL] [Abstract][Full Text] [Related]